Subscribe
Tada Images / Shutterstock.com
17 April 2025NewsAmericas

USPTO speeds up patent issuance amid widespread agency changes

Prompter patent issue will provide earlier protection for inventions and could avoid need for Quick Path Information Disclosure Statements, says USPTO.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Panitch Schwarze hires experienced ex-USPTO examiner
27 March 2025   Combining USPTO work with a background in molecular biology, immunology, and plant biochemistry, the new counsel brings patent practitioner and examiner skills to the firm.
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025   As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa Woutersen.
Americas
Trump chooses crypto-focused litigation funding expert to lead USPTO
13 March 2025   John Squires’ IP monetisation history offers clues to his interests, but supporters say his focus on business and innovation signals a positive shift for the office.


Editor's picks

AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

Editor's picks

Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025

More on this story

Careers
Panitch Schwarze hires experienced ex-USPTO examiner
27 March 2025   Combining USPTO work with a background in molecular biology, immunology, and plant biochemistry, the new counsel brings patent practitioner and examiner skills to the firm.
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025   As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa Woutersen.
Americas
Trump chooses crypto-focused litigation funding expert to lead USPTO
13 March 2025   John Squires’ IP monetisation history offers clues to his interests, but supporters say his focus on business and innovation signals a positive shift for the office.

More on this story

Careers
Panitch Schwarze hires experienced ex-USPTO examiner
27 March 2025   Combining USPTO work with a background in molecular biology, immunology, and plant biochemistry, the new counsel brings patent practitioner and examiner skills to the firm.
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025   As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa Woutersen.
Americas
Trump chooses crypto-focused litigation funding expert to lead USPTO
13 March 2025   John Squires’ IP monetisation history offers clues to his interests, but supporters say his focus on business and innovation signals a positive shift for the office.

More features

Fenwick establishes new Boston office with trio of IP partners from Cooley
How pharma should prep for the six-bill avalanche from Congress
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Lathrop GPM adds portfolio management specialist
Fed Circ decides fate of Orange Book patent covering blockbuster J&J schizophrenia drug
Failure to make findings of fact adds twist to battle over Eliquis in Ireland
Novo Nordisk, Bayer, GSK among giants accused in drug delivery suits
BMS notches legal win and FDA nod